The global increase in obesity has led to a redoubling of efforts directed at understanding the control of energy homeostasis. Insight into the mechanisms which govern appetite regulation is central to understanding the pathophysiology of obesity and the design of effective therapeutic interventions. Exploitation of hormonal satiety signals secreted by the gut requires greater insight into their interaction with central nervous system (CNS) circuits of appetite control. Manganese-enhanced magnetic resonance imaging is a novel technique, recently adapted to investigate the effects of gut peptides on CNS appetite circuits. Using manganese ion accumulation as a marker of neuronal activity, changes in signal intensity in key appetite centres within the hypothalamus following peripheral injection of gut hormones have been demonstrated. Manganese-enhanced magnetic resonance imaging offers several advantages over methodologies currently used for the study of gut hormone interactions with the CNS and has the potential for application in fields beyond appetite regulation.

Keywords:
Manganese-enhanced magnetic resonance imaging, Central nervous system, Arcuate nucleus, Neuropeptide Y, Pro-opiomelanocortin, Blood brain barrier
1.
Elmquist JK, Coppari R, Balthasar N, Ichinose M, Lowell BB: Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis. J Comp Neurol 2005;493:63–71.
2.
Chaudhri OB, Salem V, Murphy KG, Bloom SR: Gastrointestinal satiety signals. Annu Rev Physiol 2008;70:239–255.
3.
Peruzzo B, Pastor FE, Blazquez JL, Schobitz K, Pelaez B, Amat P, Rodriguez EM: A second look at the barriers of the medial basal hypothalamus. Exp Brain Res 2000;132:10–26.
4.
Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ: The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 2001;25(suppl 5):S63–S67.
5.
Ellacott KL, Halatchev IG, Cone RD: Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 2006;27:340–349.
6.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003;37:649–661.
7.
Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000;141:4255–4261.
8.
Van Den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D: Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 2004;7:493–494.
9.
Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K: The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett 1997;224:149–152.
10.
Badman MK, Flier JS: The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007;132:2103–2115.
11.
Wardlaw SL: Clinical review 127: obesity as a neuroendocrine disease: lessons to be learned from proopiomelanocortin and melanocortin receptor mutations in mice and men. J Clin Endocrinol Metab 2001;86:1442–1446.
12.
Cone RD: Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005;8:571–578.
13.
Ritter RC: Gastrointestinal mechanisms of satiation for food. Physiol Behav 2004;81:249–273.
14.
Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH: The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 2001;74:683–701.
15.
Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K, Niijima A, Furuya M, Inomata N, Osuye K, Nakazato M: The role of the vagal nerve in peripheral PYY3–36-induced feeding reduction in rats. Endocrinology 2005;146:2369–2375.
16.
Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, Nakazato M: The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120–1128.
17.
Härfstrand A, Fuxe K, Agnati LF, Benfenati F, Goldstein M: Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. Acta Physiol Scand 1986;128:195–200.
18.
Williams DL, Kaplan JM, Grill HJ: The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology 2000;141:1332–1337.
19.
Batterham RL, Ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, Williams SC: PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007;450:106–109.
20.
Malik S, McGlone F, Bedrossian D, Dagher A: Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008;7:400–409.
21.
Nair DG: About being BOLD. Brain Res Rev 2005;50:229–243.
22.
Ojemann JG, Akbudak E, Snyder AZ, McKinstry RC, Raichle ME, Conturo TE: Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts. Neuroimage 1997;6:156–167.
23.
Petersen ET, Zimine I, Ho YC, Golay X: Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006;79:688–701.
24.
Hewson AK, Dickson SL: Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J Neuroendocrinol 2000;12:1047–1049.
25.
Olszewski PK, Grace MK, Billington CJ, Levine AS: Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 2003;24:919–923.
26.
Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, Bloom SR: Oxyntomodulin inhibits food intake in the rat. Endocrinology 2001;142:4244–4250.
27.
Baggio LL, Huang Q, Brown TJ, Drucker DJ: Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 2004;127:546–558.
28.
Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR: Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 2002;418:650–654.
29.
Herrera DG, Robertson HA: Activation of c-fos in the brain. Prog Neurobiol 1996;50:83–107.
30.
Curran T, Morgan JI: Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995;26:403–412.
31.
Harris JA: Using c-fos as a neural marker of pain. Brain Res Bull 1998;45:1–8.
32.
Luckman SM, Dyball RE, Leng G: Induction of c-fos expression in hypothalamic magnocellular neurons requires synaptic activation and not simply increased spike activity. J Neurosci 1994;14:4825–4830.
33.
Yu K, Chen Q, Liu H, Zhan Y, Stevens JL: Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells. J Cell Physiol 1994;161:303–311.
34.
Yamamori T: CDF/LIF selectively increases c-fos and jun-B transcripts in sympathetic neurons. Neuroreport 1991;2:173–176.
35.
Roca A, Shin KJ, Liu X, Simon MI, Chen J: Comparative analysis of transcriptional profiles between two apoptotic pathways of light-induced retinal degeneration. Neuroscience 2004;129:779–790.
36.
Stark JA, Davies KE, Williams SR, Luckman SM: Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. Neuroimage 2006;31:1228–1237.
37.
Lin YJ, Koretsky AP: Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med 1997;38:378–388.
38.
Silva AC, Lee JH, Aoki I, Koretsky AP: Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004;17:532–543.
39.
Mendonca-Dias MH, Gaggelli E, Lauterbur PC: Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983;13:364–376.
40.
Fornasiero D, Bellen JC, Baker RJ, Chatterton BE: Paramagnetic complexes of manganese(II), iron(III), and gadolinium(III) as contrast agents for magnetic resonance imaging. The influence of stability constants on the biodistribution of radioactive aminopolycarboxylate complexes. Invest Radiol 1987;22:322–327.
41.
Kang YS, Gore JC: Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences. Invest Radiol 1984;19:399–407.
42.
Saeed M, Higgins CB, Geschwind JF, Wendland MF: T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 2000;10:310–318.
43.
Crossgrove JS, Allen DD, Bukaveckas BL, Rhineheimer SS, Yokel RA: Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. Neurotoxicology 2003;24:3–13.
44.
Aoki I, Wu YJ, Silva AC, Lynch RM, Koretsky AP: In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 2004;22:1046–1059.
45.
Watanabe T, Natt O, Boretius S, Frahm J, Michaelis T: In vivo 3D MRI staining of mouse brain after subcutaneous application of MnCl2. Magn Reson Med 2002;48:852–859.
46.
Drapeau P, Nachshen DA: Manganese fluxes and manganese-dependent neurotransmitter release in presynaptic nerve endings isolated from rat brain. J Physiol 1984;348:493–510.
47.
Hunter DR, Haworth RA, Berkoff HA: Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. J Mol Cell Cardiol 1981;13:823–832.
48.
Simpson PB, Challiss RA, Nahorski SR: Divalent cation entry in cultured rat cerebellar granule cells measured using Mn2+ quench of fura 2 fluorescence. Eur J Neurosci 1995;7:831–840.
49.
Narita K, Kawasaki F, Kita H: Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 1990;510:289–295.
50.
Hallam TJ, Rink TJ: Agonists stimulate divalent cation channels in the plasma membrane of human platelets. FEBS Lett 1985;186:175–179.
51.
Shibuya I, Douglas WW: Indications from Mn-quenching of Fura-2 fluorescence in melanotrophs that dopamine and baclofen close Ca channels that are spontaneously open but not those opened by high [K+]O; and that Cd preferentially blocks the latter. Cell Calcium 1993;14:33–44.
52.
Neuwelt EA, Hill SA, Frenkel EP, Diehl JT, Maravilla KR, Vu LH, Clark WK, Rapoport SI, Barnett PA, Lewis SE, Ehle AL, Beyer CW Jr: Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Cancer Treat Rep 1981;65(suppl 2):39–43.
53.
Morita H, Ogino T, Seo Y, Fujiki N, Tanaka K, Takamata A, Nakamura S, Murakami M: Detection of hypothalamic activation by manganese ion contrasted T(1)-weighted magnetic resonance imaging in rats. Neurosci Lett 2002;326:101–104.
54.
Aoki I, Tanaka C, Takegami T, Ebisu T, Umeda M, Fukunaga M, Fukuda K, Silva AC, Koretsky AP, Naruse S: Dynamic activity-induced manganese-dependent contrast magnetic resonance imaging (DAIM MRI). Magn Reson Med 2002;48:927–933.
55.
Kawasaki M, Yamaguchi K, Saito J, Ozaki Y, Mera T, Hashimoto H, Fujihara H, Okimoto N, Ohnishi H, Nakamura T, Ueta Y: Expression of immediate early genes and vasopressin heteronuclear RNA in the paraventricular and supraoptic nuclei of rats after acute osmotic stimulus. J Neuroendocrinol 2005;17:227–237.
56.
Duong TQ, Silva AC, Lee SP, Kim SG: Functional MRI of calcium-dependent synaptic activity: cross correlation with CBF and BOLD measurements. Magn Reson Med 2000;43:383–392.
57.
Sloot WN, Gramsbergen JB: Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 1994;657:124–132.
58.
Pautler RG, Fraser SE: The year(s) of the contrast agent – micro-MRI in the new millennium. Curr Opin Immunol 2003;15:385–392.
59.
Pautler RG: In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004;17:595–601.
60.
Takeda A, Kodama Y, Ishiwatari S, Okada S: Manganese transport in the neural circuit of rat CNS. Brain Res Bull 1998;45:149–152.
61.
Pautler RG, Koretsky AP: Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 2002;16:441–448.
62.
Pautler RG, Silva AC, Koretsky AP: In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998;40:740–748.
63.
Van der Linden A, Verhoye M, Van Meir V, Tindemans I, Eens M, Absil P, Balthazart J: In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience 2002;112:467–474.
64.
Saleem KS, Pauls JM, Augath M, Trinath T, Prause BA, Hashikawa T, Logothetis NK: Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 2002;34:685–700.
65.
Kuo YT, Herlihy AH, So PW, Bhakoo KK, Bell JD: In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride. J Magn Reson Imaging 2005;21:334–339.
66.
Kuo YT, Parkinson JR, Chaudhri OB, Herlihy AH, So PW, Dhillo WS, Small CJ, Bloom SR, Bell JD: The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging. J Neurosci 2007;27:12341–12348.
67.
Brightman MW, Broadwell RD: The morphological approach to the study of normal and abnormal brain permeability. Adv Exp Med Biol 1976;69:41–54.
68.
Aschner M: The transport of manganese across the blood-brain barrier. Neurotoxicology 2006;27:311–314.
69.
Allegrini PR, Wiessner C: Three-dimensional MRI of cerebral projections in rat brain in vivo after intracortical injection of MnCl2. NMR Biomed 2003;16:252–256.
70.
Morita H, Ogino T, Fujiki N, Tanaka K, Gotoh TM, Seo Y, Takamata A, Nakamura S, Murakami M: Sequence of forebrain activation induced by intraventricular injection of hypertonic NaCl detected by Mn2+ contrasted T1-weighted MRI. Auton Neurosci 2004;113:43–54.
71.
Banks WA, Tschop M, Robinson SM, Heiman ML: Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002;302:822–827.
72.
Nonaka N, Shioda S, Niehoff ML, Banks WA: Characterization of blood-brain barrier permeability to PYY3–36 in the mouse. J Pharmacol Exp Ther 2003;306:948–953.
73.
Kuo YT, Herlihy AH, So PW, Bhakoo KK, Bell JD: In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride. J Magn Reson Imaging 2005;21:334–339.
74.
Kuo YT, Herlihy AH, So PW, Bell JD: Manganese-enhanced magnetic resonance imaging (MEMRI) without compromise of the blood-brain barrier detects hypothalamic neuronal activity in vivo. NMR Biomed 2006;19:1028–1034.
75.
Chaudhri OB, Parkinson JR, Kuo YT, Druce MR, Herlihy AH, Bell JD, Dhillo WS, Stanley SA, Ghatei MA, Bloom SR: Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun 2006;350:298–306.
76.
Fraser KA, Raizada E, Davison JS: Oral-pharyngeal-esophageal and gastric cues contribute to meal-induced c-fos expression. Am J Physiol 1995;268:R223–R230.
77.
Glatzle J, Kreis ME, Kawano K, Raybould HE, Zittel TT: Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors. Am J Physiol Regul Integr Comp Physiol 2001;281:R222–R229.
78.
Timofeeva E, Picard F, Duclos M, Deshaies Y, Richard D: Neuronal activation and corticotropin-releasing hormone expression in the brain of obese (fa/fa) and lean (fa/?) Zucker rats in response to refeeding. Eur J Neurosci 2002;15:1013–1029.
79.
Zhang YP, Ma C, Wen YQ, Wang JJ: Convergence of gastric vagal and cerebellar fastigial nuclear inputs on glycemia-sensitive neurons of lateral hypothalamic area in the rat. Neurosci Res 2003;45:9–16.
80.
Holzer P: Afferent signalling of gastric acid challenge. J Physiol Pharmacol 2003;54(suppl 4):43–53.
81.
Timofeeva E, Richard D: Activation of the central nervous system in obese Zucker rats during food deprivation. J Comp Neurol 2001;441:71–89.
82.
Riediger T, Bothe C, Becskei C, Lutz TA: Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 2004;79:317–326.
83.
Miller I, Ronnett GV, Moran TH, Aja S: Anorexigenic C75 alters c-Fos in mouse hypothalamic and hindbrain subnuclei. Neuroreport 2004;15:925–929.
84.
Gautron L, Mingam R, Moranis A, Combe C, Laye S: Influence of feeding status on neuronal activity in the hypothalamus during lipopolysaccharide-induced anorexia in rats. Neuroscience 2005;134:933–946.
85.
Johnstone LE, Fong TM, Leng G: Neuronal activation in the hypothalamus and brainstem during feeding in rats. Cell Metab 2006;4:313–321.
86.
Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480–484.
87.
Ovesjo ML, Gamstedt M, Collin M, Meister B: GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J Neuroendocrinol 2001;13:505–516.
88.
Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278:135–138.
89.
Van der LA, Van CN, Ramos-Cabrer P, Hoehn M: Current status of functional MRI on small animals: application to physiology, pathophysiology, and cognition. NMR Biomed 2007;20:522–545.
90.
Wolf GL, Baum L: Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR Am J Roentgenol 1983;141:193–197.
91.
Finley JW: Does environmental exposure to manganese pose a health risk to healthy adults? Nutr Rev 2004;62:148–153.
92.
Aoki I, Ebisu T, Tanaka C, Katsuta K, Fujikawa A, Umeda M, Fukunaga M, Takegami T, Shapiro EM, Naruse S: Detection of the anoxic depolarization of focal ischemia using manganese-enhanced MRI. Magn Reson Med 2003;50:7–12.
93.
Bouret SG, Gorski JN, Patterson CM, Chen S, Levin BE, Simerly RB: Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. Cell Metab 2008;7:179–185.
94.
Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL: Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004;304:110–115.
95.
Bouret SG, Draper SJ, Simerly RB: Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004;304:108–110.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.